LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

LLY

732.4

+0.01%↑

JNJ

177.02

+0.87%↑

ABBV

210.3

+1.16%↑

UNH

309.45

+2.3%↑

AZN

79.89

-0.16%↓

Search

MannKind Corp

Gesloten

SectorGezondheidszorg

4.59 2

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

4.5

Max

4.61

Belangrijke statistieken

By Trading Economics

Inkomsten

-12M

668K

Verkoop

-1.8M

77M

K/W

Sectorgemiddelde

35.455

35.724

Winstmarge

0.873

Werknemers

403

EBITDA

-17M

9.7M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+105.45% upside

Dividenden

By Dow Jones

Volgende Winsten

6 nov 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

5.2M

1.2B

Vorige openingsprijs

2.59

Vorige sluitingsprijs

4.59

Nieuwssentiment

By Acuity

15%

85%

22 / 372 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

MannKind Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

29 aug 2025, 18:43 UTC

Belangrijke Marktbewegers

Privia Health Shares Advance on Outlook Bump From Medicare Savings

29 aug 2025, 15:07 UTC

Acquisities, Fusies, Overnames

Strathcona Resources to Increase Minority Stake in MEG Energy, Vote Against Cenovus Buyout Plan

29 aug 2025, 20:50 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Auto & Transport Roundup: Market Talk

29 aug 2025, 20:24 UTC

Winsten

Earnings Season Highlights on Tariffs, Consumer Spending, and More -- Barrons.com

29 aug 2025, 20:17 UTC

Winsten

These Stocks Moved the Most Today: Alibaba, Marvell, Affirm, Nvidia, Dell, Autodesk, Ambarella, IREN, and More -- Barrons.com

29 aug 2025, 19:18 UTC

Marktinformatie

Oil Futures End Week With Modest Gains -- Market Talk

29 aug 2025, 18:59 UTC

Marktinformatie

U.S. Natural Gas Futures Post Weekly Gains -- Market Talk

29 aug 2025, 18:36 UTC

Winsten

These Were the Best & Worst S&P 500 Stocks in August -- Barrons.com

29 aug 2025, 18:26 UTC

Winsten

What the Stock Market Learned About Earnings and Consumers This Summer -- Barrons.com

29 aug 2025, 17:48 UTC

Marktinformatie

U.S. Oil Rig Count Increases By 1 to 412 -- Market Talk

29 aug 2025, 17:10 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Regulator Firing Clears Path for Union Pacific-Norfolk Southern Deal -- Market Talk

29 aug 2025, 16:57 UTC

Winsten

These Stocks Are Moving the Most Today: Alibaba, Marvell, Affirm, Nvidia, Dell, Autodesk, Ambarella, IREN, and More -- Barrons.com

29 aug 2025, 16:30 UTC

Acquisities, Fusies, Overnames

Celsius Stock Is Spiking After PepsiCo Increases Stake -- Barrons.com

29 aug 2025, 16:28 UTC

Acquisities, Fusies, Overnames

BBVA: Adjustment Intended to Maintain Equivalent Economic Terms of Offer Following Dividend Payments by Sabadell

29 aug 2025, 16:27 UTC

Acquisities, Fusies, Overnames

BBVA: Adjustment Outlined in Announcement on May 9, 2024

29 aug 2025, 16:26 UTC

Acquisities, Fusies, Overnames

BBVA Now Offering 1 Newly Issued Ordinary BBVA Share and EUR0.70 in Cash for Every 5.5483 Ordinary Shares of Sabadell

29 aug 2025, 16:25 UTC

Acquisities, Fusies, Overnames

BBVA: Adjustment Factors in Interim Dividend Paid by Sabadell to Its Shareholders

29 aug 2025, 16:24 UTC

Acquisities, Fusies, Overnames

BBVA Adjusts Offer for Banco de Sabadell

29 aug 2025, 16:23 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Strathcona's Power Play in MEG Energy Jeopardizes Cenovus Deal -- Market Talk

29 aug 2025, 16:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

29 aug 2025, 16:06 UTC

Marktinformatie

Gold Futures Gain as U.S. Inflation Data Boost Rate Cut Hopes -- Market Talk

29 aug 2025, 15:12 UTC

Marktinformatie
Winsten

Best Buy Surprise Comp Growth Potentially Driven by Switch 2 -- Market Talk

29 aug 2025, 15:09 UTC

Winsten

Small-Cap Stocks Are Rallying Again. This Time It's Real. -- Barrons.com

29 aug 2025, 15:01 UTC

Marktinformatie

Canadian Economy Expected to Slow But Grow in 2H -- Market Talk

29 aug 2025, 14:49 UTC

Winsten

These Stocks Are Moving the Most Today: Marvell, Dell, Nvidia, Alibaba, Affirm, Autodesk, Ambarella, IREN, and More -- Barrons.com

29 aug 2025, 14:49 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

29 aug 2025, 14:49 UTC

Marktinformatie

Canada May Avoid Contraction in 3Q, But Is Expected to Struggle -- Market Talk

29 aug 2025, 14:48 UTC

Winsten

Marvell Stock Tumbles. Why the AI Chip Player Keeps Disappointing the Market. -- Barrons.com

29 aug 2025, 14:43 UTC

Marktinformatie

Rise in Canadian Household Spending May Not Worry Central Bank -- Market Talk

29 aug 2025, 14:38 UTC

Marktinformatie

With Canada's Economy Soft, Central Bank Easing Looks Likely -- Market Talk

Peer Vergelijking

Prijswijziging

MannKind Corp Prognose

Koersdoel

By TipRanks

105.45% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 9.43 USD  105.45%

Hoogste 12 USD

Laagste 7 USD

Gebaseerd op 7 Wall Street-analisten die 12-maands prijsdoelen bieden voor MannKind Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

7 ratings

7

Buy

0

Hold

0

Sell

Technische score

By Trading Central

4.079 / 4.323Steun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

Weak Bearish Evidence

Sentiment

By Acuity

22 / 372 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over MannKind Corp

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes, and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults. The company's product pipeline also includes Tyvaso DPI (Treprostinil), an inhalation powder for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; MNKD-101, a nebulized formulation of clofazimine, for the treatment of severe chronic and recurrent pulmonary infections, including nontuberculous mycobacterial lung disease; MNKD-201, a dry-powder formulation of nintedanib, for the treatment of idiopathic pulmonary fibrosis (IPF). In addition, it has collaboration and license agreement with United Therapeutics Corporation for development, regulatory, and commercial activities of Tyvaso DPI; co-promotion agreement with Vertice Pharma to promote Thyquidity; and collaboration agreement with Thirona to evaluate the therapeutic for the treatment of pulmonary fibrosis. Further, the company has supply and distribution agreement with Biomm S.A. for the commercialization of Afrezza in Brazil; and license and distribution agreement with Cipla Ltd. for the marketing and distribution of Afrezza in India. MannKind Corporation was incorporated in 1991 and is headquartered in Danbury, Connecticut.